标题
The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
作者
关键词
-
出版物
Cancers
Volume 10, Issue 8, Pages 271
出版商
MDPI AG
发表日期
2018-08-15
DOI
10.3390/cancers10080271
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer
- (2018) Michael B. Streiff et al. AMERICAN JOURNAL OF HEMATOLOGY
- Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism
- (2018) Chatree Chai-Adisaksopha et al. AMERICAN JOURNAL OF MEDICINE
- Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119)
- (2018) L. Tittl et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
- (2018) Ang Li et al. THROMBOSIS RESEARCH
- Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
- (2017) Hakeam A. Hakeam et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low Molecular Weight Heparins as Extended Prophylaxis Against Recurrent Thrombosis in Cancer Patients
- (2017) Cocav A. Engman et al. Journal of the National Comprehensive Cancer Network
- Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study
- (2016) Simon Mantha et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Direct Oral Anticoagulants in Patients With VTE and Cancer
- (2015) Maria Cristina Vedovati et al. CHEST
- Recurrence of Venous Thromboembolism in Patients With Cancer Treated With Warfarin
- (2015) Ariela L. Marshall et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
- (2015) Agnes Y. Y. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer-Associated Venous Thromboembolic Disease, Version 1.2015
- (2015) Michael B. Streiff et al. Journal of the National Comprehensive Cancer Network
- Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis
- (2015) S. Schulman et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
- (2014) N. van Es et al. BLOOD
- Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis
- (2014) Ryma Ihaddadene et al. THROMBOSIS RESEARCH
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2013) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies
- (2013) Jay Desai et al. THROMBOSIS AND HAEMOSTASIS
- Antithrombotic Therapy for VTE Disease
- (2012) Clive Kearon et al. CHEST
- Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier
- (2012) F. CAMPIGOTTO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2012) D. FARGE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism
- (2011) S. Parpia et al. Contemporary Clinical Trials
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients
- (2009) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started